Mr. Roe Holdings Announces Strategic Partnership with GATC Health
New investment round to accelerate AI driven drug discovery platform development, strengthening our position in healthcare innovation.
Blog & Updates
Investor updates, research progress, and real-time protocol journals from Sage Roe and the Mr. Roe Holdings team. Covering GATC Health, ONIT Holdings, Compound 89™, and CRP+™.
Latest Articles
Company News
New investment round to accelerate AI driven drug discovery platform development, strengthening our position in healthcare innovation.
Third party verified results show 40% improvement in sustainable farming practices across partner farms nationwide.
Strategic additions strengthen advisory capabilities across healthcare and technology sectors.
Mr. Roe Holdings expands portfolio with strategic investment in sustainable energy infrastructure.
Our perspective on how artificial intelligence is transforming drug discovery and precision medicine.
Expanding sustainable farming initiatives through new technology partnerships.